Cancer BiologyMolecular PharmaceuticsPeer-reviewed
A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25
Alberto Guillermo Arias, Laura Tovar-Martinez, Eliana K. Asciutto…·Pablo Scodeller
This paper identifies a cyclic peptide, CES, that targets glioblastoma by binding to aberrantly exposed SNAP25, showing its potential as a drug delivery tool and molecular marker.
7 citations